Cloudbyz

MAY 17, 2024

This Act is poised to significantly change the clinical trials landscape within the life sciences sector. As AI increasingly becomes a cornerstone in clinical research and drug development, it is crucial for industry stakeholders to grasp the extensive implications of this regulation.

Life Science 102

Life Science Clinical Trials Clinical Trials Trials 102

XTalks

DECEMBER 10, 2024

The surge in MASH cases stresses the need for early diagnosis, timely intervention and precise, reliable methodologies in clinical trials to evaluate new therapies effectively. Read on to gain insights from Medpace experts about advancements in imaging, histology and innovative techniques for MASH clinical trials.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Clinical Research 105

ACRP blog

OCTOBER 10, 2024

The same is true in life sciences. As the technology develops, however, it will offer more opportunities to expedite drug discovery processes, streamline clinical trials, and speed up regulatory approvals. MGI puts the value of this contribution to clinical development at $15 billion to $25 b illion.

Clinical Trials 69

Clinical Trials Clinical Trials Trials Life Science 69

XTalks

NOVEMBER 15, 2024

Syros Pharmaceuticals announced that its cancer drug tamibarotene failed to meet its primary endpoint in the SELECT-MDS-1 Phase III trial. The placebo-controlled SELECT-MDS-1 trial involved 190 patients with complete response rate (CRR) being the study’s primary endpoint. percent and 18.8

Trials 105

Trials HR Immune Response FDA Approval 105

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 9, 2024

Experts in the life-sciences industry are of the view that doing away with human studies for new drugs in India is unscientific and risky as patients here have different anthropometry.

Trials 185

Trials Life Science Clinical Trials Clinical Trials 185

XTalks

APRIL 17, 2025

Their discussion shows how meaningful partnerships, deep listening and unwavering patient-centricity can transform clinical research, trial design and care delivery in rare conditions such as HPP. Early collaborations in clinical trial design enabled both teams to integrate critical patient insights into study protocols.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

XTalks

MARCH 12, 2025

Following the success of Issue 3 , which focused on the critical importance of patient diversity in clinical research, Xtalks is thrilled to announce Xtalks Clinical Edge Issue 4. These prominent leaders will share their experiences, strategies and visions about whats next for clinical research.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

XTalks

DECEMBER 10, 2024

In the trial, platelet response, defined as achieving at least 50,000 platelets per microliter or doubling baseline counts, was seen in 65 percent of patients on rilzabrutinib, compared to 33 percent on placebo. Participants received either rilzabrutinib or placebo for 24 weeks, followed by an open-label extension.

Trials 104

Trials Protein Clinical Development Drugs 104

XTalks

MARCH 26, 2025

In the fast-evolving field of clinical research, thought leaders do more than just keep up; they lead the charge and shape the direction of the industry. Heres how thought leaders are currently making an impact in clinical research: 1.

Clinical Research 52

Clinical Research Research Branding Clinical Trials 52

Cloudbyz

MARCH 17, 2024

In the dynamic world of life sciences, where innovation is paramount, the integration of cutting-edge technologies is crucial for accelerating clinical operations and driving breakthroughs in healthcare. Salesforce’s recent announcement of its Life Sciences Cloud marks a significant stride towards this goal.

Life Science 81

Life Science Clinical Trials Clinical Trials Trials 81

XTalks

NOVEMBER 19, 2024

In clinical research, diversity is more than a prerequisite for a successful drug — it’s a critical component that enhances the validity and applicability of clinical trial outcomes. Diversity Action Plans have now moved from being a “nice-to-have” to a “must-have” in clinical trial designs.

Clinical Trials 64

Clinical Trials Clinical Trials Trials Production 64

pharmaphorum

JANUARY 25, 2021

The clinical research community has been disrupted in a number of ways due to COVID-19 and sparked a spirit of collaboration and innovation. Worldwide Clinical Trial’s Aman Khera gives five predictions of how clinical research could change in 2021. clinical trial diversity.

Clinical Research 125

Clinical Research Research Clinical Trials Clinical Trials 125

Velocity Clinical Research

MARCH 23, 2025

Clinical trials have been steadily leaving the UK for years. of patients recruited to global trials were from the UK. Thats not to say we dont still have some clout (the UK ranks fourth globally for Phase II trials ), but the trending outflow needs to be addressed. In 2021, just 2.2%

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

XTalks

MAY 12, 2021

In the life sciences, like many industries, working from home will likely remain more prevalent than it was pre-pandemic even after it’s safe for employees to return to the office. However, this trying year has highlighted the shortfalls the life science industry continues to struggle with.

Life Science 95

Life Science Engineer Clinical Trials Clinical Trials 95

XTalks

DECEMBER 26, 2024

Menarini Group has announced positive topline data from the Phase III BROADWAY and TANDEM clinical trials, evaluating obicetrapib and the fixed-dose combination of obicetrapib with ezetimibe. Meanwhile, the TANDEM trial evaluated a fixed-dose combination of obicetrapib with 10 mg ezetimibe in a similar patient population.

Trials 52

Trials Life Science Clinical Trials Clinical Trials 52

pharmaphorum

FEBRUARY 24, 2022

For example, during the height of the pandemic, NIHR’s integrated health research system was able to compare COVID-19 hospital caseloads to COVID-19 research activity in real time. This enabled rapid recruitment to multiple COVID-19 clinical trials throughout England/UK. . About the panellist’s.

Clinical Research 105

Clinical Research Research Life Science Clinical Trials 105

XTalks

DECEMBER 12, 2024

In clinical research, this includes designing trials that elevate the patient voice, reduce barriers to participation, and represent the diverse populations who will ultimately use these medical products. Access to information: Limited resources and educational materials hinder informed decision-making about trial participation.

Clinical Trials 59

Clinical Trials Clinical Trials Clinical Research Trials 59

XTalks

SEPTEMBER 9, 2024

Diversity, equity and inclusion (DEI) have become important elements in the landscape of clinical research. Xtalks spoke with Stacy Weil, DHI, Senior Vice President, Business Operations and Patient Centricity, Premier Research, to gain insights into incorporating DEI practices and plans in clinical research.

Clinical Research 101

Clinical Research Research Clinical Trials Clinical Trials 101

pharmaphorum

NOVEMBER 17, 2020

Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. He works with patient groups and advocates globally, with academics and industry, and with researchers and clinicians.

Clinical Trials 116

Clinical Trials Clinical Trials Trials Life Science 116

ACRP blog

JANUARY 12, 2023

Taking action to increase and diversify the clinical research workforce is a high priority at Merck, known as MSD outside the U.S. Merck and the Association of Clinical Research Professionals (ACRP) are partnering on two pivotal new programs to grow and diversify the clinical research workforce for sites.”.

Clinical Research 98

Clinical Research Research Clinical Trials Clinical Trials 98

XTalks

AUGUST 22, 2023

Recruiting participants is perhaps the most challenging aspect of any clinical trial, regardless of the therapeutic area. Yet this one piece is also the most vital, with a trial’s ability to enroll and retain participants being a key predictor of a study’s future success. What is Clinical Trials For All?

Clinical Trials 97

Clinical Trials Clinical Trials Trials Clinical Research 97

Imperical Blog

APRIL 10, 2025

Changes taking place in the United States and internationally may affect the clinical trials landscape in the months and even years to come. … The post Keeping Clinical Trials on Track: Navigating Supply Chains, Tariffs, and Regulatory Shifts. appeared first on Imperial Clinical Research Services Blog. .…

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

XTalks

APRIL 13, 2022

Pediatric rare disease clinical trials are vital to determining the safety and efficacy of medications for children living with a rare disease. Therefore, pediatric rare disease clinical trials are vital to determining the safety and efficacy of medications for children living with a rare disease. adults).

Clinical Trials 98

Clinical Trials Clinical Trials Clinical Research Trials 98

XTalks

APRIL 15, 2025

The landscape of rare disease clinical trials has seen significant transformation over the past decade. However, many challenges remain in ensuring patient access, optimizing trial design and leveraging technological advancements to improve outcomes.

Trials 52

Trials Clinical Trials Clinical Trials Gene Therapy 52

XTalks

NOVEMBER 13, 2024

Merck KGaA recently shared positive results from its Phase III MANEUVER trial on pimicotinib, an investigational oral therapy for tenosynovial giant cell tumor (TGCT). These findings align with early trial results, reinforcing pimicotinib’s promise for improving daily function in TGCT patients. percent of patients.

Clinical Research 105

Clinical Research FDA Approval Trials Research 105

XTalks

APRIL 3, 2025

Eli Lilly shared new Phase II trial data showing that its experimental siRNA therapy, lepodisiran, leads to reductions in levels of lipoprotein(a) (Lp(a)) a genetically inherited risk factor for heart disease in adults with elevated levels of the marker. The 400 mg dose was the highest lepodisiran dose in the trial.

Trials 59

Trials Clinical Trials Clinical Trials Genetics 59

XTalks

MARCH 11, 2025

XTALKS WEBINAR: Redefining Womens Cancer Care: Delivering Smarter, Safer Clinical Trials Live and On-Demand: Thursday, April 10, 2025, at 11am EDT (4pm BST/UK) Register for this free webinar to explore innovative approaches to enhancing clinical trials for breast and gynecological cancers.

Trials 59

Trials Clinical Trials Clinical Trials Protein 59

Pharmaceutical Technology

JUNE 8, 2023

Data in clinical trials For example, huge amounts of data can be mined from electronic health records (EHRs) and other sources to optimise clinical research, from drug identification to treatment plan design.

Clinical Research 130

Clinical Research Research Clinical Trials Clinical Trials 130

BioPharma Reporter

JULY 23, 2024

As a strategic brand consultant at ramarketing, Laura Childs combines her extensive background in clinical research with strategic leadership and creative expression.

Life Science 95

Life Science Branding Clinical Research Research 95

XTalks

DECEMBER 9, 2024

Despite its potential to slow cognitive decline, the delays highlight the challenges of timely drug approval for life-threatening conditions. Notably, the FDA can now mandate that confirmatory trials begin before approval, ensuring proactive validation of clinical benefits.

Clinical Trials 105

Clinical Trials Clinical Trials Compliance Trials 105

pharmaphorum

FEBRUARY 2, 2021

Previously viewed as a ‘nice to have’ for the pharma industry, virtual trials were already moving from a theoretical to a practical proposition before COVID-19 accelerated their transition. Increasing patient access to clinical trials. Ensuring new types of trial designs remain patient friendly.

Clinical Research 71

Clinical Research Trials Research Clinical Trials 71

XTalks

DECEMBER 3, 2024

Building on this history of success, Novocure recently revealed promising Phase III results from the PANOVA-3 clinical trial, marking a significant milestone in pancreatic cancer treatment. Novocure’s broader pipeline underscores the versatility of TTFields therapy.

Trials 105

Trials Immune Response Clinical Trials Clinical Trials 105

Clinical Trial Podcast

JULY 31, 2022

Who owns the clinical trial data generated in industry sponsored or investigator initiated clinical trials? What responsibilities do Sponsors, CROs, or Sites have when it comes to sharing clinical trial results with patients? To answer these questions and more, I invited Darshan Kulkarni to the show.

Clinical Research 80

Clinical Research Clinical Trials Clinical Trials Research 80

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 3, 2024

Navigating regulatory affairs in the biopharma industry requires a skilled talent pool, according to Benjamin James, HR Leader, Asia-Pacific, Cytiva Lifesciences – a global life sciences (biopharma) company. in 2021 to 5.60 […]

HR 183

HR Life Science Clinical Trials Clinical Trials 183

XTalks

NOVEMBER 20, 2023

Xtalks’ recent discussion with Rebekah Angove, PhD, Executive VP of Research and Evaluation at the Patient Advocate Foundation (PAF), offers a deeper understanding of incorporating patient narratives into clinical trials. Patients frequently approach us, exploring clinical research as a potential care option.

Clinical Research 90

Clinical Research Research Clinical Trials Clinical Trials 90

XTalks

JANUARY 24, 2024

In this episode, Ayesha talked about some of the trends in the life sciences to watch out for in 2024. Hear about the latest technologies and approaches that will help drive innovations in drug discovery, clinical research and medical device design this year.

Life Science 52

Life Science Clinical Research Drugs Development 52

XTalks

NOVEMBER 15, 2024

Current treatment options remain limited, and many patients have not had opportunities to participate in trials specifically tailored to their condition. Interim results from Longboard’s Phase II PACIFIC study, involving DEE participants aged 12 to 65, previously supported bexicaserin’s transition to this Phase III trial.

Trials 97

Trials Clinical Trials Clinical Trials Genetics 97